tirzepatide 10 ml Dosing: Diabetes vs Weight Loss Mounjaro (Tirzepatide) Injection 7.5 mg/0.5

Behrends, U

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

Some patients find that taking semaglutide at a different time of day or with specific foods reduces discomfort

Although strict glycemic control has beneficial effects on microvascular complications (retinopathy, nephropathy or neuropathy), it does not seem to reduce the risk of cardiovascular disease, and it is associated with an increased risk of hypoglycemia in patients with DM2.3,6 Until recently, the antihyperglycemic drugs available have improved glycemic control, but without much benefits on cardiovascular and/or renal risk

With so many lawsuits being filed, it is important for consumers to be aware of the potential risk